Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: We aimed to investigate the predictive factors for early response to methimazole (MMI) in pediatric patients with Graves disease (GD). Methods: Our study included 44 pediatric patients who were diagnosed with GD between January 1, 1993, and December 31, 2013, and were available for followup, achieving a normalization of thyroid functions (TFs) at the Chonbuk National University Hospital Pediatric Department. We retrospectively analyzed TFs such as tri-iodothyronine (T3), free thyroxine (fT4), thyroid-stimulating hormone (TSH), and thyroid antibody levels at diagnosis. We also examined their family history of thyroid disease, symptoms at presentation, and normalization time for TF after treatment. We divided our clinical series of patients into the following 4 age groups: <7 years old, 7–12 years old, 13–15 years old, and 16–18 years old. Results: At diagnosis, the time of normalization of T3 was significantly shorter in the higher antimicrosomal antibody (AMA) group compared with the lower AMA group (2.53 months vs. 6.18 months) (P<0.05). However, the time of normalization of T3/fT4/TSH had no significant correlations with other variables such as age, sex, a family history of thyroid diseases, thyroglobulin, thyroid-stimulating immunoglobulin, or antithyroglobulin antibody (ATA). Conclusion: Higher serological titers of AMA at diagnosis may have prognostic value in the response to initial MMI treatment in pediatric hyperthyroid GD patients.
Abstract
Purpose: We aimed to investigate the predictive factors for early response to methimazole (MMI) in pediatric patients with Graves disease (GD). Methods: Our study included 44 pediatric patients who were diagnosed with GD between January 1, 1993, and December 31, 2013, and were available for followup, achieving a normalization of thyroid functions (TFs) at the Chonbuk National University Hospital Pediatric Department. We retrospectively analyzed TFs such as tri-iodothyronine (T3), free thyroxine (fT4), thyroid-stimulating hormone (TSH), and thyroid antibody levels at diagnosis. We also examined their family history of thyroid disease, symptoms at presentation, and normalization time for TF after treatment. We divided our clinical series of patients into the following 4 age groups: <7 years old, 7–12 years old, 13–15 years old, and 16–18 years old. Results: At diagnosis, the time of normalization of T3 was significantly shorter in the higher antimicrosomal antibody (AMA) group compared with the lower AMA group (2.53 months vs. 6.18 months) (P<0.05). However, the time of normalization of T3/fT4/TSH had no significant correlations with other variables such as age, sex, a family history of thyroid diseases, thyroglobulin, thyroid-stimulating immunoglobulin, or antithyroglobulin antibody (ATA). Conclusion: Higher serological titers of AMA at diagnosis may have prognostic value in the response to initial MMI treatment in pediatric hyperthyroid GD patients.
참고문헌 (26)
- Bettendorf M, "Thyroid disorders in children from birth to adolescence", Eur J Nucl Med Mol Imaging, 29(Suppl 2), pp.S439~S446 (2002)
- Sperling MA, "Pediatric endocrinology", pp.187~209 (2002), WB Saunders Co
- Jaruratanasirikul S, "Thyrotoxicosis in children: treatment and outcome", J Med Assoc Thai, 89, pp.967~973 (2006)
- Abraham-Nordling M, "Incidence of hyperthyroidism in Sweden", Eur J Endocrinol, 165, pp.899~905 (2011)
- Metso S, "Graves' disease", N Engl J Med, 359, pp.1408~1409 (2008)
- Sperling MA, "Pediatric endocrinology", pp.12~453 (2014), WB Saunders Co
- Krassas GE, "A questionnaire survey concerning the most favourable treatment for Graves' disease in children and adolescents", Eur J Endocrinol, 151, pp.155~156 (2004)
- Webster J, "Graves' disease in children", CMAJ, 169, pp.104~105 (2003)
- Gruneiro-Papendieck L, "Pediatric Graves' disease: outcome and treatment", J Pediatr Endocrinol Metab, 16, pp.1249~1255 (2003)
- Lippe BM, "Hyperthyroidism in children treated with long term medical therapy: twentyfive percent remission every two years", J Clin Endocrinol Metab, 64, pp.1241~1245 (1987)
- Abraham P, "Current and emerging treatment options for Graves' hyperthyroidism", Ther Clin Risk Manag, 6, pp.29~40 (2010)
- Kliegman RM, "Nelson textbook of pediatrics" (2011), Elsevier
- Bahn Chair RS, "Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists", Thyroid, 21, pp.593~646 (2011)
- Foley TP Jr, "Thyrotoxicosis in childhood", Pediatr Ann, 21, pp.43~46 (1992)
- Zimmerman D, "Thyrotoxicosis in children", Endocrinol Metab Clin North Am, 27, pp.109~126 (1998)
- Brook CG, "Clinical paedriatric endocrinology", pp.419~422 (1995), Blackwell Science Ltd
- Rivkees SA, "An optimal treatment for pediatric Graves' disease is radioiodine", J Clin Endocrinol Metab, 92, pp.797~800 (2007)
- Lee JA, "The optimal treatment for pediatric Graves' disease is surgery", J Clin Endocrinol Metab, 92, pp.801~803 (2007)
- Cooper DS, "Antithyroid drugs", N Engl J Med, 352, pp.90517~ (2005)
- Allahabadia A, "Age and gender predict the outcome of treatment for Graves' hyperthyroidism", J Clin Endocrinol Metab, 85, pp.1038~1042 (2000)
- Benker G, "Response to methimazole in Graves' disease. The European Multicenter Study Group", Clin Endocrinol (Oxf), 43, pp.257~263 (1995)
- Hamada N, "Retrospective reevaluation of the significance of thyroid microsomal antibody in the treatment of Graves'disease", Acta Endocrinol (Copenh), 114, pp.328~335 (1987)
- Doniach D, "Human auto-immune thyroiditis: clinical studies", Br Med J, 1, pp.365~373 (1960)
- 김현미, "소아 Graves병의 임상적 고찰:사춘기 이전군과 사춘기군의 비교", Korean Journal of Pediatrics, 46(1), pp.76~82 (2003), 대한소아과학회
- 송승민, "한국 소아 및 청소년 Graves병의 자연 경과 및 예후 인자", Korean Journal of Pediatrics, 53(4), pp.585~591 (2010), 대한소아과학회
- 이선희, "소아 및 청소년 그레이브스병 환자에서의 관해 예측 인자와 관해율", Korean Journal of Pediatrics, 52(9), pp.1021~1028 (2009), 대한소아과학회